Krushi Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Secunderabad, Telangana, India, established in 2012.
2012 Secunderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Krushi Pharma Private Limited

Krushi Pharma Private Limited, a struck off private limited company, was established on 29 March 2012 in Secunderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232TG2012PTC080002. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Karunakar Reddy Malgireddy (Director), Pasham Narsimha Reddy (Director). Past directors included Boodati Radha Krishnaiah, Mahesh Goli, Laxmaiah Ramulamma Venkatesh Balli. It is based at Flat No.103, H.No.8-2-68/1,1St Floor, Sri Sai Viahala Residency, Old Bowenpall, Y,, Secunderabad, Telangana, 500011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PTC080002

  • Registration Number

    080002

  • Incorporation Date

    29 March 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 10 Months
Company report

Krushi Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Krushi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Krushi Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Karunakar Reddy Malgireddy Director 01 Jan 2014 Current
Pasham Narsimha Reddy Director 29 Mar 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Sep 2014 Past
Pramod Abcsdd Director 05 Aug 2013 Past
Pramod Abcsdd Director 05 Aug 2013 Past
Pramod Abcsdd Director 07 Jan 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Krushi Pharma.

Enhance accessibility to Krushi Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Krushi Pharma revenue growth over time
Krushi Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Krushi Pharma?

Unlock access to Krushi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Krushi Pharma?

Unlock and access historical data on people associated with Krushi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Krushi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krushi Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Krushi Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Karunakar Reddy Malgireddy was appointed as a Director was appointed as a Director on 01 Jan 2014 & has been associated with this company since 12 years 1 month . was documented.

  • Director Appointment

    The activity Pasham Narsimha Reddy was appointed as a Director was appointed as a Director on 29 Mar 2012 & has been associated with this company since 13 years 10 months . was completed.

  • Company Incorporation

    The activity Krushi Pharma Private Limited was registered on 29 Mar 2012 with Roc Hyderabad & aged 13 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Krushi Pharma Private Limited?

The CIN of Krushi Pharma Private Limited is U24232TG2012PTC080002.

Where is Krushi Pharma Private Limited headquartered?

Krushi Pharma Private Limited is headquartered at Flat No.103, H.No.8-2-68/1,1St Floor, Sri Sai Viahala Residency, Old Bowenpall, Y,, Secunderabad, Telangana, 500011.

When was Krushi Pharma Private Limited incorporated?

Krushi Pharma Private Limited was incorporated on 29 March 2012.

Who are the current directors of Krushi Pharma Private Limited?

The current directors of Krushi Pharma Private Limited are

What is the primary industry of Krushi Pharma Private Limited?

The primary industry of Krushi Pharma Private Limited is Chemicals.

Is Krushi Pharma Private Limited a listed company?

Krushi Pharma Private Limited is unlisted.

What is the capital structure of Krushi Pharma Private Limited?

The authorized capital of Krushi Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available